Cost-Effectiveness Analysis of Triple Combination Preparations in the Treatment of Moderate-to-Severe Chronic Obstructive Pulmonary Disease

Objectives: This study analyzed the long-term cost-effectiveness of fluticasone/umeclidinium/vilanterol triple combination (FF/UMEC/VI) vs. budesonide/formoterol double combination (BUD/FOR) in the treatment of moderate-to-severe chronic obstructive pulmonary disease (COPD) and provides evidence for...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yikang, Long, Enwu, Xu, Qian, Wang, Lei, Jiang, Xuehua, Hu, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355539/
https://www.ncbi.nlm.nih.gov/pubmed/34395374
http://dx.doi.org/10.3389/fpubh.2021.713258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355539/
https://www.ncbi.nlm.nih.gov/pubmed/34395374
http://dx.doi.org/10.3389/fpubh.2021.713258

Ejemplares similares